Consensus-Based Technical Recommendations for Clinical Translation of Renal Phase Contrast MRI
- PMID: 33140551
- PMCID: PMC9291014
- DOI: 10.1002/jmri.27419
Consensus-Based Technical Recommendations for Clinical Translation of Renal Phase Contrast MRI
Abstract
Background: Phase-contrast (PC) MRI is a feasible and valid noninvasive technique to measure renal artery blood flow, showing potential to support diagnosis and monitoring of renal diseases. However, the variability in measured renal blood flow values across studies is large, most likely due to differences in PC-MRI acquisition and processing. Standardized acquisition and processing protocols are therefore needed to minimize this variability and maximize the potential of renal PC-MRI as a clinically useful tool.
Purpose: To build technical recommendations for the acquisition, processing, and analysis of renal 2D PC-MRI data in human subjects to promote standardization of renal blood flow measurements and facilitate the comparability of results across scanners and in multicenter clinical studies.
Study type: Systematic consensus process using a modified Delphi method.
Population: Not applicable.
Sequence field/strength: Renal fast gradient echo-based 2D PC-MRI.
Assessment: An international panel of 27 experts from Europe, the USA, Australia, and Japan with 6 (interquartile range 4-10) years of experience in 2D PC-MRI formulated consensus statements on renal 2D PC-MRI in two rounds of surveys. Starting from a recently published systematic review article, literature-based and data-driven statements regarding patient preparation, hardware, acquisition protocol, analysis steps, and data reporting were formulated.
Statistical tests: Consensus was defined as ≥75% unanimity in response, and a clear preference was defined as 60-74% agreement among the experts.
Results: Among 60 statements, 57 (95%) achieved consensus after the second-round survey, while the remaining three showed a clear preference. Consensus statements resulted in specific recommendations for subject preparation, 2D renal PC-MRI data acquisition, processing, and reporting.
Data conclusion: These recommendations might promote a widespread adoption of renal PC-MRI, and may help foster the set-up of multicenter studies aimed at defining reference values and building larger and more definitive evidence, and will facilitate clinical translation of PC-MRI.
Level of evidence: 1 TECHNICAL EFFICACY STAGE: 1.
Keywords: consensus; kidney; phase-contrast MRI; renal blood flow; standardization.
© 2020 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC. on behalf of International Society for Magnetic Resonance in Medicine.
Conflict of interest statement
Dr. Ruth P. Lim declares research funding support from Boehringer Ingelheim and See‐Mode Technologies. Dr. Paul D. Hockings is an employee at Antaros Medical. Dr. Michael Bock has Research Cooperation with Siemens Healthcare. Dr. Yasuo Takehara has an endowed chair at Nagoya University, supported by a private company. All other authors have nothing to declare.
Figures
References
-
- Helal I, Reed B, Schrier RW. Emergent early markers of renal progression in autosomal‐dominant polycystic kidney disease patients: Implications for prevention and treatment. Am J Nephrol 2012;36:162‐167. - PubMed
-
- Textor SC, Lerman LO. The role of hypoxia in ischemic chronic kidney disease. Semin Nephrol 2019;39:589‐598. - PubMed
-
- Brenna S, Grigoras O, Drukker A, Guignard J‐P. Pitfalls in measuring inulin and para‐amino‐hippuric acid clearances. Pediatr Nephrol 1998;12:489‐491. - PubMed
-
- Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium‐based contrast agent: A systematic review and meta‐analysis. JAMA Intern Med 2020;180:223‐230. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
